avapro has been researched along with Weight Loss in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Weight Loss: Decrease in existing BODY WEIGHT.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xiao, P | 1 |
Gao, C | 1 |
Fan, J | 1 |
Du, H | 1 |
Long, Y | 1 |
Yin, Y | 1 |
Parhofer, KG | 1 |
Münzel, F | 1 |
Krekler, M | 1 |
1 trial available for avapro and Weight Loss
Article | Year |
---|---|
Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure | 2007 |
1 other study available for avapro and Weight Loss
Article | Year |
---|---|
Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial F | 2011 |